| ID_events | cancer | TypeID | ImmuneCell | P | R | CorrelationPlot |
| chr1:36138737-36139478:- | BLCA | EER | Dendritic_cells_resting | 1.1834e-02 | 0.3313 |  |
| ENSG00000054116.10,TRAPPC3 | BLCA | EAG | Dendritic_cells_resting | 1.1116e-02 | 0.3311 |  |
| chr1:36138737-36139478:- | BRCA | EER | NK_cells_activated | 3.0770e-02 | -0.1330 |  |
| ENSG00000054116.10,TRAPPC3 | BRCA | EAG | B_cells_naive | 2.5329e-02 | -0.1369 |  |
| chr1:36138737-36139478:- | CESC | EER | B_cells_memory | 4.6604e-02 | 0.3088 |  |
| ENSG00000054116.10,TRAPPC3 | CESC | EAG | B_cells_memory | 4.6604e-02 | 0.3088 |  |
| ENSG00000054116.10,TRAPPC3 | ESCA | EAG | Mast_cells_activated | 6.2530e-03 | 0.4060 |  |
| chr1:36138737-36139478:- | GBM | EER | B_cells_naive | 4.1996e-03 | -0.2505 |  |
| ENSG00000054116.10,TRAPPC3 | GBM | EAG | B_cells_naive | 4.1996e-03 | -0.2505 |  |
| ENSG00000054116.10,TRAPPC3 | HNSC | EAG | B_cells_memory | 4.1012e-02 | 0.4200 |  |
| chr1:36138737-36139478:- | KIRC | EER | T_cells_gamma_delta | 3.2639e-02 | 0.3619 |  |
| ENSG00000054116.10,TRAPPC3 | KIRC | EAG | T_cells_gamma_delta | 3.2639e-02 | 0.3619 |  |
| chr1:36138737-36139478:- | LUAD | EER | T_cells_gamma_delta | 3.4407e-02 | 0.2128 |  |
| ENSG00000054116.10,TRAPPC3 | LUAD | EAG | T_cells_gamma_delta | 3.4407e-02 | 0.2128 |  |
| chr1:36138737-36139478:- | LUSC | EER | T_cells_gamma_delta | 3.6858e-02 | 0.2180 |  |
| ENSG00000054116.10,TRAPPC3 | LUSC | EAG | T_cells_gamma_delta | 3.6910e-02 | 0.2179 |  |
| chr1:36138737-36139478:- | OV | EER | B_cells_memory | 2.8243e-03 | 0.2834 |  |
| ENSG00000054116.10,TRAPPC3 | OV | EAG | B_cells_memory | 2.1948e-03 | 0.2758 |  |
| ENSG00000054116.10,TRAPPC3 | PAAD | EAG | T_cells_CD4_memory_activated | 2.0931e-02 | 0.5002 |  |
| chr1:36138737-36139478:- | SARC | EER | T_cells_gamma_delta | 2.7739e-02 | -0.3319 |  |
| ENSG00000054116.10,TRAPPC3 | SARC | EAG | T_cells_gamma_delta | 2.7739e-02 | -0.3319 |  |
| ENSG00000054116.10,TRAPPC3 | STAD | EAG | Plasma_cells | 1.8934e-02 | 0.2723 |  |
| chr1:36138737-36139478:- | THCA | EER | Mast_cells_activated | 2.7301e-02 | 0.1111 |  |
| ENSG00000054116.10,TRAPPC3 | THCA | EAG | Mast_cells_activated | 2.7301e-02 | 0.1111 |  |
| ENSG00000054116.10,TRAPPC3 | THYM | EAG | Neutrophils | 1.1703e-03 | 0.6458 |  |
| ID_events | cancer | HallmarkType | Type | P | R | CorrelationPlot |
| ENSG00000054116.10,TRAPPC3 | BLCA | GSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE | EAG | 4.9939e-02 | 0.2587 |  |
| ENSG00000054116.10,TRAPPC3 | BRCA | GSVA_HALLMARK_CHOLESTEROL_HOMEOSTASIS | EAG | 4.9356e-04 | 0.2118 |  |
| chr1:36138737-36139478:- | BRCA | GSVA_HALLMARK_CHOLESTEROL_HOMEOSTASIS | EER | 1.9598e-03 | 0.1897 |  |
| chr1:36138737-36139478:- | CESC | GSVA_HALLMARK_CHOLESTEROL_HOMEOSTASIS | EER | 1.1024e-02 | -0.3884 |  |
| ENSG00000054116.10,TRAPPC3 | CESC | GSVA_HALLMARK_CHOLESTEROL_HOMEOSTASIS | EAG | 1.1024e-02 | -0.3884 |  |
| ENSG00000054116.10,TRAPPC3 | GBM | GSVA_HALLMARK_HEME_METABOLISM | EAG | 8.6738e-04 | 0.2897 |  |
| chr1:36138737-36139478:- | GBM | GSVA_HALLMARK_HEME_METABOLISM | EER | 8.6738e-04 | 0.2897 |  |
| ENSG00000054116.10,TRAPPC3 | HNSC | GSVA_HALLMARK_KRAS_SIGNALING_UP | EAG | 4.3568e-02 | 0.4153 |  |
| ENSG00000054116.10,TRAPPC3 | KIRC | GSVA_HALLMARK_KRAS_SIGNALING_DN | EAG | 3.6348e-02 | 0.3551 |  |
| chr1:36138737-36139478:- | KIRC | GSVA_HALLMARK_KRAS_SIGNALING_DN | EER | 3.6348e-02 | 0.3551 |  |
| ENSG00000054116.10,TRAPPC3 | KIRP | GSVA_HALLMARK_ESTROGEN_RESPONSE_LATE | EAG | 2.0194e-02 | -0.4616 |  |
| chr1:36138737-36139478:- | LGG | GSVA_HALLMARK_ESTROGEN_RESPONSE_LATE | EER | 2.2929e-02 | 0.1700 |  |
| ENSG00000054116.10,TRAPPC3 | LGG | GSVA_HALLMARK_ESTROGEN_RESPONSE_LATE | EAG | 2.2929e-02 | 0.1700 |  |
| chr1:36138737-36139478:- | LUSC | GSVA_HALLMARK_XENOBIOTIC_METABOLISM | EER | 1.3126e-02 | 0.2577 |  |
| ENSG00000054116.10,TRAPPC3 | LUSC | GSVA_HALLMARK_XENOBIOTIC_METABOLISM | EAG | 1.3183e-02 | 0.2576 |  |
| chr1:36138737-36139478:- | OV | GSVA_HALLMARK_MYC_TARGETS_V2 | EER | 4.2696e-02 | 0.1945 |  |
| ENSG00000054116.10,TRAPPC3 | OV | GSVA_HALLMARK_MYC_TARGETS_V2 | EAG | 2.2545e-02 | 0.2073 |  |
| ENSG00000054116.10,TRAPPC3 | PAAD | GSVA_HALLMARK_MYC_TARGETS_V2 | EAG | 6.1438e-03 | 0.5773 |  |
| ENSG00000054116.10,TRAPPC3 | PRAD | GSVA_HALLMARK_ESTROGEN_RESPONSE_LATE | EAG | 3.4770e-02 | 0.1890 |  |
| chr1:36138737-36139478:- | PRAD | GSVA_HALLMARK_ESTROGEN_RESPONSE_LATE | EER | 3.4770e-02 | 0.1890 |  |
| chr1:36138737-36139478:- | SARC | GSVA_HALLMARK_PI3K_AKT_MTOR_SIGNALING | EER | 9.7835e-03 | 0.3854 |  |
| ENSG00000054116.10,TRAPPC3 | SARC | GSVA_HALLMARK_PI3K_AKT_MTOR_SIGNALING | EAG | 9.7835e-03 | 0.3854 |  |
| ENSG00000054116.10,TRAPPC3 | SKCM | GSVA_HALLMARK_COAGULATION | EAG | 6.2955e-03 | 0.2290 |  |
| ENSG00000054116.10,TRAPPC3 | STAD | GSVA_HALLMARK_PANCREAS_BETA_CELLS | EAG | 1.4070e-02 | 0.2844 |  |
| ENSG00000054116.10,TRAPPC3 | THYM | GSVA_HALLMARK_ESTROGEN_RESPONSE_EARLY | EAG | 4.7115e-03 | -0.5794 |  |
| ID_events | cancer | Drug | Type | P | R | CorrelationPlot |
| ENSG00000054116.10,TRAPPC3 | BLCA | ABT.263 | EAG | 4.8834e-02 | -0.2599 |  |
| chr1:36138737-36139478:- | BLCA | ABT.263 | EER | 4.4364e-02 | -0.2674 |  |
| ENSG00000054116.10,TRAPPC3 | BRCA | Cisplatin | EAG | 1.1572e-03 | -0.1978 |  |
| chr1:36138737-36139478:- | BRCA | Cisplatin | EER | 7.8865e-04 | -0.2054 |  |
| chr1:36138737-36139478:- | CESC | KIN001.135 | EER | 6.5506e-03 | 0.4131 |  |
| ENSG00000054116.10,TRAPPC3 | CESC | KIN001.135 | EAG | 6.5506e-03 | 0.4131 |  |
| ENSG00000054116.10,TRAPPC3 | ESCA | Cisplatin | EAG | 3.6132e-02 | -0.3168 |  |
| ENSG00000054116.10,TRAPPC3 | GBM | Lapatinib | EAG | 1.0320e-03 | -0.2857 |  |
| chr1:36138737-36139478:- | GBM | Lapatinib | EER | 1.0320e-03 | -0.2857 |  |
| ENSG00000054116.10,TRAPPC3 | HNSC | ABT.888 | EAG | 2.3299e-02 | -0.4612 |  |
| ENSG00000054116.10,TRAPPC3 | KIRC | CHIR.99021 | EAG | 1.3034e-02 | 0.4156 |  |
| chr1:36138737-36139478:- | KIRC | CHIR.99021 | EER | 1.3034e-02 | 0.4156 |  |
| ENSG00000054116.10,TRAPPC3 | KIRP | BMS.754807 | EAG | 3.3549e-02 | 0.4264 |  |
| chr1:36138737-36139478:- | LGG | AZD6482 | EER | 3.9071e-02 | 0.1544 |  |
| ENSG00000054116.10,TRAPPC3 | LGG | AZD6482 | EAG | 3.9071e-02 | 0.1544 |  |
| chr1:36138737-36139478:- | LUAD | GNF.2 | EER | 3.8597e-02 | -0.2083 |  |
| ENSG00000054116.10,TRAPPC3 | LUAD | GNF.2 | EAG | 3.8597e-02 | -0.2083 |  |
| chr1:36138737-36139478:- | LUSC | Lapatinib | EER | 1.1600e-02 | -0.2635 |  |
| ENSG00000054116.10,TRAPPC3 | LUSC | Lapatinib | EAG | 1.1583e-02 | -0.2636 |  |
| chr1:36138737-36139478:- | OV | Gemcitabine | EER | 8.4142e-03 | -0.2512 |  |
| ENSG00000054116.10,TRAPPC3 | OV | AKT.inhibitor.VIII | EAG | 3.3966e-03 | 0.2643 |  |
| ENSG00000054116.10,TRAPPC3 | PAAD | FH535 | EAG | 4.7740e-02 | 0.4368 |  |
| ENSG00000054116.10,TRAPPC3 | PCPG | AG.014699 | EAG | 4.9857e-02 | 0.3046 |  |
| ENSG00000054116.10,TRAPPC3 | PRAD | Gefitinib | EAG | 5.3747e-05 | 0.3531 |  |
| chr1:36138737-36139478:- | PRAD | Gefitinib | EER | 5.3747e-05 | 0.3531 |  |
| chr1:36138737-36139478:- | SARC | Gefitinib | EER | 4.1989e-03 | 0.4233 |  |
| ENSG00000054116.10,TRAPPC3 | SARC | Gefitinib | EAG | 4.1989e-03 | 0.4233 |  |
| ENSG00000054116.10,TRAPPC3 | SKCM | CEP.701 | EAG | 2.0970e-02 | -0.1943 |  |
| ENSG00000054116.10,TRAPPC3 | STAD | Metformin | EAG | 1.3179e-02 | -0.2870 |  |
| ENSG00000054116.10,TRAPPC3 | THYM | EHT.1864 | EAG | 1.2342e-02 | -0.5238 |  |